Features of MRI of the prostate gland when planning targeted biopsy with combined ultrasound and magnetic resonance imaging control

Cover Page

Cite item

Full Text

Abstract

.

About the authors

A. L. Burulev

North-Western State Medical University named after I.I. Mechnikov

Author for correspondence.
Email: artmed@mail.ru
Russian Federation, 41, Kirochnaya street, Saint Petersburg, 191015

I. E. Itskovich

North-Western State Medical University named after I.I. Mechnikov

Email: artmed@mail.ru
Russian Federation, 41, Kirochnaya street, Saint Petersburg, 191015

M. A. Kakheli

North-Western State Medical University named after I.I. Mechnikov

Email: artmed@mail.ru
Russian Federation, 41, Kirochnaya street, Saint Petersburg, 191015

References

  1. Zyryanov AV, Popov IB, Ponomarev AV, et al. Targeted prostate biopsy under MRI control (fusion). Academic journal of West Siberia. 2016;12(4):28–30. (In Russ).
  2. Rosenkrantz AB, Verma S, Choyke P., et al. Prostate magnetic resonance imaging and magnetic resonance imaging targeted biopsy in patients with a prior negative biopsy: a consensus statement by AUA and SAR. J Urol. 2016;196(6):1613–1618. doi: 10.1016/j.juro.2016.06.079
  3. De Gorski A, Mozer P, Roupret M, et al. En cas de premiere serie de biopsies de prostate, les biopsies prostatiques ciblees par voie transrectale avec fusion echo/IRM ont un meilleur rendement que les biopsies standard pour la detection de cancer significatif dans les prostates > 40 mL. Progres en Urologie. 2014;24(13):813. doi: 10.1016/j.purol.2014.08.068

Copyright (c) 2021 Burulev A.L., Itskovich I.E., Kakheli M.A.

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies